A. Elattar

发表

Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?

S. Kehoe, C. Cummins, Kavita Singh, 2020, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis

N. Curtin, R. Edmondson, A. McCormick, 2014, PloS one.

The use of sentinel node sampling in vulval cancer

A. Notghi, R. Ganesan, D. Luesley, 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

The NICE classification for ‘Ultra‐radical (extensive) surgery for advanced ovarian cancer’ guidance does not meaningfully predict postoperative complications: a cohort study

S. Kehoe, S. Sundar, A. Phillips, 2018, BJOG : an international journal of obstetrics and gynaecology.

Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer

S. Kehoe, Kavita Singh, S. Sundar, 2017, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Serum Albumin as a Predictor of Survival after Interval Debulking Surgery for Advanced Ovarian Cancer (AOC): A Retrospective Study

S. Kehoe, Kavita Singh, S. Sundar, 2020, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.

S. Kehoe, Kavita Singh, S. Sundar, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias

A. Bryant, R. Naik, A. Elattar, 2022, American journal of therapeutics.

Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis

A. Bryant, D. Craig, R. Naik, 2022, BMJ Open.

Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.

A. Bryant, D. Craig, Tafadzwa Patience Kunonga, 2021, The Cochrane database of systematic reviews.

Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.

S. Kehoe, Kavita Singh, S. Sundar, 2018, European journal of obstetrics, gynecology, and reproductive biology.

Diaphragm disease in advanced ovarian cancer

S. Kehoe, Kavita Singh, S. Sundar, 2018 .

The Impact of Supraclavicular Irradiation on Thyroid Function and Size in Postoperative Breast Cancer Patients by Comparing 2 D versus 3 D-CRT

A. Mohamed, A. Elattar, Ahmad M. Alhosainy, 2016 .

C. Robson, R. Edmondson, A. Elattar, 2009, British Journal of Cancer.

University The NICE classification for "Ultra-radical (extensive) surgery for advanced ovarian cancer" guidance does not meaningfully predict post-operative complications

S. Kehoe, Kavita Singh, S. Sundar, 2018 .

Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis

A. Bryant, D. Craig, R. Naik, 2022, American journal of therapeutics.

The evolving role of one-step nucleic acid amplification (OSNA) for the intra-operative detection of lymph node metastases: A diagnostic accuracy meta-analysis.

S. Kehoe, A. Tranoulis, D. Georgiou, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival.

P. Maxwell, N. Curtin, W. McCluggage, 2012, Cancer research.

Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors

Y. Drew, N. Curtin, Z. Hostomský, 2010, Clinical Cancer Research.

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.

Paul Cross, C. Robson, R. Edmondson, 2012, Gynecologic oncology.

Short Term Results of Fixation of Unstable Thoracolumbar Fractures with and without Intermediate Screws: A Comparative Study

A. Elattar, Moustafa Elsayed, Ahmed A. H. Abdellatif, 2021 .

A comparative study between the Universal Spinal System® (USS) and the CD Horizon® Legacy™ (CDH) in the management of thoracolumbar fractures

W. Koptan, Yasser H Elmiligui, A. Elattar, 2019, SICOT-J.

Surgical cytoreduction for recurrent epithelial ovarian cancer.

A. Lopes, R. Bristow, A. Bryant, 2013, The Cochrane database of systematic reviews.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

A. Bryant, R. Naik, B. Winter-Roach, 2011, The Cochrane database of systematic reviews.

Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre

S. Kehoe, Kavita Singh, S. Sundar, 2020, Gynecologic Oncology.

Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy

S. Kehoe, Kavita Singh, I. Fernando, 2019, Archives of Gynecology and Obstetrics.

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study

S. Kehoe, Kavita Singh, S. Sundar, 2015, International Journal of Gynecologic Cancer.

Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.

S. Kehoe, Kavita Singh, S. Sundar, 2017, Gynecologic oncology.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

A. Bryant, R. Naik, B. Winter-Roach, 2011, The Cochrane database of systematic reviews.

Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.

S. Kehoe, Kavita Singh, S. Sundar, 2017, Gynecologic oncology.